Followers

7
7
4
4
.
1
1
7
7
-2.90 (-3.90%)

As on 05 Dec, 2025 | 15:55

Open Trading A/c
Day Range
70.05
74.00
LH
52 Week Range
70.05
132.00
LH
Volume
* i
Bid / Ask
11,111.00
0.00 / 0.00

Bal Pharma Announcements

We are submitting to the exchanges, news paper advertisements of the unaudited standalone and consolidated financial results of the company for the quarter ended 30.09.2029...

17 Nov, 2025 | 04:17pm • Source: BSE

Unaudited standalone and Consolidated financial results for the quarter ended 30.09.2025.

12 Nov, 2025 | 06:56pm • Source: BSE

Board of Directors of the Company has inter alia 1. Approved the unaudited standalone and consolidate financial results for the quarter ended 30.09.2025. 2. Appointed...

12 Nov, 2025 | 06:49pm • Source: BSE

Clarification on the outcome of the board meeting held on 11.08.2025.

07 Nov, 2025 | 03:00pm • Source: BSE

Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and...

04 Nov, 2025 | 04:44pm • Source: BSE

Compliance Certificate for the quarter ended 30.09.2025, as per SEBI(PIT) Regulations,2015

24 Oct, 2025 | 12:28pm • Source: NSE

Confirmation as per Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 30.09.2025.

06 Oct, 2025 | 12:11pm • Source: BSE

Completion of term of Mr.H.S Venkatesh ( DIN # 01776040) as Independent Director of the Company.

30 Sep, 2025 | 03:12pm • Source: BSE

Trading Window on dealing with the securities of the Company will be closed from 1st October 2025 until 48 hours of announcement of Unaudited financial...

26 Sep, 2025 | 04:18pm • Source: BSE

Outcome of the 38th Annual General Meeting of the Company.

25 Sep, 2025 | 03:41pm • Source: BSE

Newpaper Publication for Notice for the 38th Annual General Meeting of the Company together with e-voting and Book closure .

03 Sep, 2025 | 04:13pm • Source: BSE

We are submitting the Copy of the unabridged Annual Report, for the financial year ended 31.03.2025.

02 Sep, 2025 | 03:26pm • Source: BSE

Newpaper Publication of the Unaudited financial results for the quarter ended 30.06.2025.

13 Aug, 2025 | 05:00pm • Source: BSE

The Board of Directors at their meeting held on 11.08.2025 has fixed 18th September 2025 as record date for the payment of dividend for the...

12 Aug, 2025 | 05:38pm • Source: BSE

Unaudited financial results ( Standalone and consolidated ) for the quarter ended 30.06.2025.

11 Aug, 2025 | 06:09pm • Source: BSE

Board of Directors of the Company has met today and inter alia transacted the following business,1. Approved the unaudited financial results ( standalone and consolidated...

11 Aug, 2025 | 06:04pm • Source: BSE

Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 ,inter alia, to consider and...

29 Jul, 2025 | 04:47pm • Source: BSE

We are submitting to the exchanges newspaper advertisements of the notice issued to the shareholders regarding transfer of their shares to IEPF account , whose...

10 Jul, 2025 | 05:22pm • Source: BSE

Bal Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

03 Jul, 2025 | 03:06pm • Source: NSE

Certificate under Regulation 74(5) of SEBI(DP) Regulations, for the quarter ended 30.06.2025.

03 Jul, 2025 | 01:04pm • Source: BSE